Objectives: This study aimed to develop a Clinical Pathway (CP) for fibromyalgia patients based on integrative medicine. It emphasizes multidisciplinary collaboration to enhance the diagnosis and treatment process while improving pain management and overall quality of life. Methods: The study involved a review of existing fibromyalgia care pathways at the W-institute and an analysis of both domestic and international studies on the condition. Focus Group Interviews (FGI) with experts and Delphi surveys were conducted to evaluate the CP’s validity and feasibility. Based on these findings, a comprehensive CP was created, incorporating processes for diagnosis, treatment, evaluation, and management, along with clinical matrices and algorithms. Results: The literature review and expert feedback underscored the need for standardized diagnostic tools such as the Widespread Pain Index (WPI) and Symptom Severity Scale (SS). Multidisciplinary approaches, including pharmacotherapy, acupuncture, physical therapy, psychotherapy, exercise, and dietary management, were identified as effective treatment options. The Delphi survey revealed high consensus rates regarding the CP’s diagnostic appropriateness (90%), treatment efficacy (95%), and management strategy practicality (93%). Consequently, two CPs were developed—one for Western medicine and another for traditional Korean medicine hospitals—both emphasizing multidisciplinary collaboration. Conclusions: The integrative medicine-based CP for fibromyalgia patients standardizes diagnosis and organizes treatment, thereby enhancing patient quality of life and improving healthcare outcomes. Further research is necessary to assess the long-term effects of the CP and its applicability across various healthcare settings.
Objectives: This study aimed to develop a Clinical Pathway (CP) for fibromyalgia patients based on integrative medicine. It emphasizes multidisciplinary collaboration to enhance the diagnosis and treatment process while improving pain management and overall quality of life. Methods: The study involved a review of existing fibromyalgia care pathways at the W-institute and an analysis of both domestic and international studies on the condition. Focus Group Interviews (FGI) with experts and Delphi surveys were conducted to evaluate the CP’s validity and feasibility. Based on these findings, a comprehensive CP was created, incorporating processes for diagnosis, treatment, evaluation, and management, along with clinical matrices and algorithms. Results: The literature review and expert feedback underscored the need for standardized diagnostic tools such as the Widespread Pain Index (WPI) and Symptom Severity Scale (SS). Multidisciplinary approaches, including pharmacotherapy, acupuncture, physical therapy, psychotherapy, exercise, and dietary management, were identified as effective treatment options. The Delphi survey revealed high consensus rates regarding the CP’s diagnostic appropriateness (90%), treatment efficacy (95%), and management strategy practicality (93%). Consequently, two CPs were developed—one for Western medicine and another for traditional Korean medicine hospitals—both emphasizing multidisciplinary collaboration. Conclusions: The integrative medicine-based CP for fibromyalgia patients standardizes diagnosis and organizes treatment, thereby enhancing patient quality of life and improving healthcare outcomes. Further research is necessary to assess the long-term effects of the CP and its applicability across various healthcare settings.
Objectives: To examine treatment outcomes and cost of the Korean Medical Critical Pathway (CP) in the treatment of depression. Methods: This was a retrospective study. A total of 60 patients who fulfilled all the information relevant to this study were included after reviewing the electronic medical record (EMR). Among them, 30 patients who met at least 70% of the CP were assigned to the CP group and 30 patients who did not meet the CP were assigned to the non-CP group. A comparison was made between the two groups regarding their demographic characteristics, clinical characteristics, economic indices, and satisfaction with care. Clinical indices of the two groups before and after treatment were also compared. Results: The CP group exhibited notable reductions in the treatment period, number of hospital visits, cost of treatment, and subsequent visit fees when compared to the non-CP group. However, changes in questionnaire scores that indicated clinical improvement and satisfaction of care were not statistically significant between the two groups. Conclusions: This study demonstrated the efficacy of CP in the treatment of depression, particularly in terms of reducing treatment duration, hospital visits, and associated costs. While clinical outcomes were comparable between the two groups, the CP approach demonstrated advantages in reducing healthcare utilization and costs for depression management. This could lead to enhanced patient outcomes and reduced healthcare costs at the national level.
Objectives: To examine treatment outcomes and cost of the Korean Medical Critical Pathway (CP) in the treatment of depression. Methods: This was a retrospective study. A total of 60 patients who fulfilled all the information relevant to this study were included after reviewing the electronic medical record (EMR). Among them, 30 patients who met at least 70% of the CP were assigned to the CP group and 30 patients who did not meet the CP were assigned to the non-CP group. A comparison was made between the two groups regarding their demographic characteristics, clinical characteristics, economic indices, and satisfaction with care. Clinical indices of the two groups before and after treatment were also compared. Results: The CP group exhibited notable reductions in the treatment period, number of hospital visits, cost of treatment, and subsequent visit fees when compared to the non-CP group. However, changes in questionnaire scores that indicated clinical improvement and satisfaction of care were not statistically significant between the two groups. Conclusions: This study demonstrated the efficacy of CP in the treatment of depression, particularly in terms of reducing treatment duration, hospital visits, and associated costs. While clinical outcomes were comparable between the two groups, the CP approach demonstrated advantages in reducing healthcare utilization and costs for depression management. This could lead to enhanced patient outcomes and reduced healthcare costs at the national level.
Objectives: Fibromyalgia is characterized by chronic pain, fatigue, sleep disturbances, and emotional instability, making it challenging to manage with traditional single-treatment approaches. Conventional medication-based treatments often fail to provide lasting relief and enhance quality of life. This study compares the Integrative Medicine Clinical Pathway (IMCP) to the Standard Clinical Pathway (CP) in terms of pain management and quality of life improvement for fibromyalgia patients. Methods: This single-blind trial involved 26 participants with fibromyalgia, who were randomly assigned to either the CP group (n=13) or the IMCP group (n=13) for a duration of 8 weeks. The IMCP included a combination of acupuncture, pharmacopuncture, counseling, meditation, and yoga. Outcomes were assessed through various measures: pain (Widespread Pain Index [WPI], Symptom Severity Scale [SSS], Numeric Pain Rating Scale [NPRS]), quality of life (EQ-5D, EQ-VAS), emotional state (Coping with Emotions Scale Inventory [CESI]), and sleep quality (Pittsburgh Sleep Quality Index [PSQI]). Results: Participants in the IMCP group demonstrated significant improvements in pain reduction (as measured by SSS and NPRS), quality of life (EQ-5D and EQ-VAS), and emotional stability (CESI) compared to the CP group (p<0.05). However, no statistically significant differences were observed in pain areas (WPI) or sleep quality (PSQI). Conclusions: IMCP effectively reduced pain and enhanced the quality of life for fibromyalgia patients, suggesting its potential as a complementary approach alongside standard treatments. Further large-scale studies and long-term follow-up are needed to confirm these findings.
Objectives: Fibromyalgia is characterized by chronic pain, fatigue, sleep disturbances, and emotional instability, making it challenging to manage with traditional single-treatment approaches. Conventional medication-based treatments often fail to provide lasting relief and enhance quality of life. This study compares the Integrative Medicine Clinical Pathway (IMCP) to the Standard Clinical Pathway (CP) in terms of pain management and quality of life improvement for fibromyalgia patients. Methods: This single-blind trial involved 26 participants with fibromyalgia, who were randomly assigned to either the CP group (n=13) or the IMCP group (n=13) for a duration of 8 weeks. The IMCP included a combination of acupuncture, pharmacopuncture, counseling, meditation, and yoga. Outcomes were assessed through various measures: pain (Widespread Pain Index [WPI], Symptom Severity Scale [SSS], Numeric Pain Rating Scale [NPRS]), quality of life (EQ-5D, EQ-VAS), emotional state (Coping with Emotions Scale Inventory [CESI]), and sleep quality (Pittsburgh Sleep Quality Index [PSQI]). Results: Participants in the IMCP group demonstrated significant improvements in pain reduction (as measured by SSS and NPRS), quality of life (EQ-5D and EQ-VAS), and emotional stability (CESI) compared to the CP group (p<0.05). However, no statistically significant differences were observed in pain areas (WPI) or sleep quality (PSQI). Conclusions: IMCP effectively reduced pain and enhanced the quality of life for fibromyalgia patients, suggesting its potential as a complementary approach alongside standard treatments. Further large-scale studies and long-term follow-up are needed to confirm these findings.
Objectives: This study explored the effectiveness and feasibility of an integrated arts therapy program for improving the mental health of patients with mental disorders. Methods: Thirty patients with mental disorders undergoing outpatient treatment at rehabilitation facilities were randomly assigned to either an intervention group, which received 10 integrated arts therapy sessions (once weekly), or a waitlist control group. Self-efficacy, the State-Trait Anxiety Inventory, the Beck Depression Inventory-II, and the Core Seven Emotions Inventory-Short Form were administered pre-intervention, post-intervention, and at a four-week follow-up. Participants were also asked to describe their subjective experiences and feelings in program satisfaction surveys conducted post-intervention. Results: The intervention group exhibited significantly lower scores for state and trait anxieties (p<0.01) compared to the control group. There was a significant increase in joy (喜) after the intervention (p<0.01) and at follow-up (p<0.05). Conversely, sorrow (悲) decreased significantly after the intervention (p<0.01) and at follow-up (p<0.01). Thought (思) (p<0.05), depression (憂) (p<0.05), and fear (恐) (p<0.05) exhibited a notable decline at follow-up in the intervention group, in contrast to the control group. The results of the subjective surveys indicated that participants reported favorable physical, emotional, and cognitive changes. Conclusions: This study suggests that integrated arts therapy may be a feasible and effective intervention for improving self-confidence and positive emotions, while alleviating anxiety and negative emotions in patients with mental disorders. These results can inform the design of future large-scale trials.
Objectives: This study explored the effectiveness and feasibility of an integrated arts therapy program for improving the mental health of patients with mental disorders. Methods: Thirty patients with mental disorders undergoing outpatient treatment at rehabilitation facilities were randomly assigned to either an intervention group, which received 10 integrated arts therapy sessions (once weekly), or a waitlist control group. Self-efficacy, the State-Trait Anxiety Inventory, the Beck Depression Inventory-II, and the Core Seven Emotions Inventory-Short Form were administered pre-intervention, post-intervention, and at a four-week follow-up. Participants were also asked to describe their subjective experiences and feelings in program satisfaction surveys conducted post-intervention. Results: The intervention group exhibited significantly lower scores for state and trait anxieties (p< 0.01) compared to the control group. There was a significant increase in joy (喜) after the intervention (p<0.01) and at follow-up (p<0.05). Conversely, sorrow (悲) decreased significantly after the intervention (p<0.01) and at follow-up (p<0.01). Thought (思) (p<0.05), depression (憂) (p<0.05), and fear (恐) (p<0.05) exhibited a notable decline at follow-up in the intervention group, in contrast to the control group. The results of the subjective surveys indicated that participants reported favorable physical, emotional, and cognitive changes. Conclusions: This study suggests that integrated arts therapy may be a feasible and effective intervention for improving self-confidence and positive emotions, while alleviating anxiety and negative emotions in patients with mental disorders. These results can inform the design of future large-scale trials.
Objectives: Hwa-byung (HB), a culture-related anger syndrome, has traditionally been linked to middle-aged Korean women. However, recent societal changes indicate its potential prevalence among younger generations. This study aimed to compare the characteristics and symptoms of Hwa-byung between Generation M (born 1980∼1994) and Generation Z (born 1995∼2005) in South Korea. Methods: A total of 449 participants (Generation M: n=323, Generation Z: n=126) completed the HB Trait Scale, HB Symptom Scale, Emotional Labor Scale, Depression Anxiety Stress Scale, and State-Trait Anger Expression Inventory. Generational differences were analyzed using t-tests and chi-square tests, with effect sizes calculated using Cohen’s d and Cramér’s V. Results: Generation Z exhibited significantly higher scores in interpersonal difficulties (p=0.005), poor emotional expression (p=0.019), and fatalistic acceptance (p=0.025). Among HB patients, Generation Z demonstrated significantly higher scores in conversation initiation difficulties (p=0.005), fatalistic acceptance (p=0.008), and repeated guilt (p=0.041). In contrast, Generation M reported more severe somatic HB symptoms (e.g., numbness and digestive issues) and higher levels of anxiety (p=0.017) and trait anger (p=0.012). Effect sizes ranged from small to medium (Cohen’s d=0.14∼0.52). Conclusions: Hwa-byung manifests differently across generations, with Generation Z facing greater challenges in interpersonal communication and a higher tendency toward fatalistic acceptance and repeated guilt, particularly among HB patients. Generation M, on the other hand, exhibited more severe somatic symptoms and emotional distress. These findings highlight the need for generation-specific interventions: focusing on improving interpersonal skills and addressing passive coping strategies for Generation Z, while emphasizing stress management and emotional regulation for Generation M.
Objectives: Hwa-byung (HB), a culture-related anger syndrome, has traditionally been linked to middle- aged Korean women. However, recent societal changes indicate its potential prevalence among younger generations. This study aimed to compare the characteristics and symptoms of Hwa-byung between Generation M (born 1980∼1994) and Generation Z (born 1995∼2005) in South Korea. Methods: A total of 449 participants (Generation M: n=323, Generation Z: n=126) completed the HB Trait Scale, HB Symptom Scale, Emotional Labor Scale, Depression Anxiety Stress Scale, and State-Trait Anger Expression Inventory. Generational differences were analyzed using t-tests and chi-square tests, with effect sizes calculated using Cohen’s d and Cramér’s V. Results: Generation Z exhibited significantly higher scores in interpersonal difficulties (p=0.005), poor emotional expression (p=0.019), and fatalistic acceptance (p=0.025). Among HB patients, Generation Z demonstrated significantly higher scores in conversation initiation difficulties (p=0.005), fatalistic acceptance (p=0.008), and repeated guilt (p=0.041). In contrast, Generation M reported more severe somatic HB symptoms (e.g., numbness and digestive issues) and higher levels of anxiety (p=0.017) and trait anger (p=0.012). Effect sizes ranged from small to medium (Cohen’s d=0.14∼0.52). Conclusions: Hwa-byung manifests differently across generations, with Generation Z facing greater challenges in interpersonal communication and a higher tendency toward fatalistic acceptance and repeated guilt, particularly among HB patients. Generation M, on the other hand, exhibited more severe somatic symptoms and emotional distress. These findings highlight the need for generationspecific interventions: focusing on improving interpersonal skills and addressing passive coping strategies for Generation Z, while emphasizing stress management and emotional regulation for Generation M.
Objectives: This study aimed to develop a ChatGPT-based stimulation training platform for Korean medicine (KM) education to provide students with virtual patient interactions and enhance their clinical competencies and evaluate its performance. Methods: A web-based platform integrating ChatGPT API was developed using Node.js and MongoDB with a react-based frontend interface. The platform included functions for instructors to create patient scenarios and for students to conduct simulated clinical consultations. The system was piloted with 47 fourth-year KM students in a KM Neuropsychiatry course, focusing on suicide risk assessment. Student perceptions were evaluated through an anonymous survey measuring satisfaction with simulated consultation experience and AI chatbot usability. Results: Of a total of 47 students, 42 completed the survey with a response rate of 89.4%. Simulation experience received high satisfaction scores across multiple dimensions, including interest (4.44±0.62), appropriateness (4.71±0.38), knowledge acquisition (4.24±0.79), and skill development (4.14±0.62). The chatbot system demonstrated strong usability scores in usefulness (4.40±0.54), accessibility (4.42±0.56), and overall discoverability (4.43±0.63). However, students expressed some skepticism about the authenticity of virtual patient responses (3.69±0.95). Conclusions: The platform shows promise as an accessible and standardized tool for clinical education in KM. While it effectively addresses resource constraints in traditional standardized patient programs, its low authenticity ratings suggest that it should be used to complement rather than replace conventional clinical training methods. Future developments should focus on enhancing response authenticity and expanding the range of clinical scenarios while maintaining high levels of accessibility and user satisfaction.
Objectives: To analyze the current status and characteristics of registered randomized controlled trials (RCTs) of digital therapeutics (DTx) for neuropsychiatric disorders using the World Health Organization International Clinical Trials Registry Platform (WHO-ICTRP). Methods: We searched the WHO-ICTRP database using the terms ‘digital therapeutics’ and ‘digital therapeutic’ up to October 27, 2024. RCTs involving DTx interventions for neuropsychiatric disorders were included. Two independent researchers extracted and analyzed the data regarding study characteristics, participant information, intervention types, and outcome measures. Results: Among a total of 67 studies included, the United States conducted the largest proportion of trials (n=36, 53.7%). A total of 54 (80.6%) studies targeted adult participants only, while 9 (13.4%) studies included adolescents and 4 studies (6.0%) focused specifically on older adults. The most commonly studied conditions were mood disorders (n=15, 22.4%), substance use disorders (n=14, 20.9%), and anxiety disorders (n=8, 11.9%). Regarding intervention types, mobile applications were the most frequently employed (n=39, 58.2%), followed by web-based programs (n=20, 29.9%) and virtual reality-based interventions (n=3, 4.5%). Cognitive behavioral therapy-based approaches were the most common therapeutic method (n=22, 32.8%), followed by behavior modification (n=8, 11.9%) and neurocognitive training (n=5, 7.5%). The Generalized Anxiety Disorder-7 was the most frequently used outcome measure. Conclusions: Our findings indicate a substantial increase of DTx clinical trials on neuropsychiatric disorders in recent years, particularly on mood and anxiety disorders. This study might be helpful for designing future clinical trials to develop DTx for treating neuropsychiatric disorders.
Objectives: To analyze the current status and characteristics of registered randomized controlled trials (RCTs) of digital therapeutics (DTx) for neuropsychiatric disorders using the World Health Organization International Clinical Trials Registry Platform (WHO-ICTRP). Methods: We searched the WHO-ICTRP database using the terms ‘digital therapeutics’ and ‘digital therapeutic’ up to October 27, 2024. RCTs involving DTx interventions for neuropsychiatric disorders were included. Two independent researchers extracted and analyzed the data regarding study characteristics, participant information, intervention types, and outcome measures. Results: Among a total of 67 studies included, the United States conducted the largest proportion of trials (n=36, 53.7%). A total of 54 (80.6%) studies targeted adult participants only, while 9 (13.4%) studies included adolescents and 4 studies (6.0%) focused specifically on older adults. The most commonly studied conditions were mood disorders (n=15, 22.4%), substance use disorders (n=14, 20.9%), and anxiety disorders (n=8, 11.9%). Regarding intervention types, mobile applications were the most frequently employed (n=39, 58.2%), followed by web-based programs (n=20, 29.9%) and virtual reality- based interventions (n=3, 4.5%). Cognitive behavioral therapy-based approaches were the most common therapeutic method (n=22, 32.8%), followed by behavior modification (n=8, 11.9%) and neurocognitive training (n=5, 7.5%). The Generalized Anxiety Disorder-7 was the most frequently used outcome measure. Conclusions: Our findings indicate a substantial increase of DTx clinical trials on neuropsychiatric disorders in recent years, particularly on mood and anxiety disorders. This study might be helpful for designing future clinical trials to develop DTx for treating neuropsychiatric disorders.
Objectives This study aimed to analyze the current status and characteristics of registered randomized controlled trials (RCTs) focused on abdominal breathing (AB) using the World Health Organization International Clinical Trials Registry Platform (WHO-ICTRP). Methods A comprehensive search of the WHO-ICTRP database was conducted on November 18, 2024, for registered RCTs involving AB interventions. The search utilized the terms “abdominal breathing,” “abdomen breathing,” and “diaphragmatic breathing.” Two independent reviewers screened the trials and extracted data regarding study characteristics, participant information, intervention details, and outcome measures. Results Out of 81 identified registrations, 18 RCTs met the inclusion criteria. The majority of the studies were conducted in Iran (38.9%) and Pakistan (33.3%). Only 22.2% of the trials employed double-blinding or triple-blinding, while 33.3% did not incorporate any blinding. The most common target conditions included respiratory diseases (33.3%) and post-surgical care (22.2%). Significant hetero-geneity was observed in the intervention protocols, with session durations varying from 5 to 35 minutes and treatment periods ranging from single sessions to 8 weeks. Sample sizes varied from 20 to 170 participants. Notably, there were no registered AB RCTs in South Korea. Conclusions While AB is being studied across various clinical conditions, the current research reveals several limitations, including methodological weaknesses, geographical bias, and heterogeneous intervention protocols. There is a pressing need for high-quality RCTs that utilize standardized protocols and include diverse populations, particularly in South Korea, where no AB RCTs have been registered despite the country’s context of traditional medicine.
Objectives: This study aimed to analyze the current status and characteristics of registered randomized controlled trials (RCTs) focused on abdominal breathing (AB) using the World Health Organization International Clinical Trials Registry Platform (WHO-ICTRP). Methods: A comprehensive search of the WHO-ICTRP database was conducted on November 18, 2024, for registered RCTs involving AB interventions. The search utilized the terms “abdominal breathing,” “abdomen breathing,” and “diaphragmatic breathing.” Two independent reviewers screened the trials and extracted data regarding study characteristics, participant information, intervention details, and outcome measures. Results: Out of 81 identified registrations, 18 RCTs met the inclusion criteria. The majority of the studies were conducted in Iran (38.9%) and Pakistan (33.3%). Only 22.2% of the trials employed double- blinding or triple-blinding, while 33.3% did not incorporate any blinding. The most common target conditions included respiratory diseases (33.3%) and post-surgical care (22.2%). Significant heterogeneity was observed in the intervention protocols, with session durations varying from 5 to 35 minutes and treatment periods ranging from single sessions to 8 weeks. Sample sizes varied from 20 to 170 participants. Notably, there were no registered AB RCTs in South Korea. Conclusions: While AB is being studied across various clinical conditions, the current research reveals several limitations, including methodological weaknesses, geographical bias, and heterogeneous intervention protocols. There is a pressing need for high-quality RCTs that utilize standardized protocols and include diverse populations, particularly in South Korea, where no AB RCTs have been registered despite the country’s context of traditional medicine.
Objectives: Post-stroke depression (PSD) is associated with increased mortality, exacerbated cognitive impairments, and diminished quality of life. Yueju-pill (Wolgukhwan, WGH) is a traditional herbal medicine from East Asia traditionally utilized for the treatment of depression. The objective of this review was to provide credible evidence regarding the efficacy and safety of WGH in the context of post-stroke depression. Methods: Thirteen electronic databases were systematically searched until September 14, 2024, and randomized controlled trials (RCTs) evaluating WGH for PSD were reviewed. The Cochrane Risk of Bias Tool version 5.1.0 and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool were employed for quality assessment. A meta-analysis was performed to assess the efficacy and safety of WGH for PSD. Results: A total of 16 RCTs involving 1,247 participants were included in the analysis. WGH was found to significantly reduce Hamilton Depression Scale (HAMD) scores (standardized mean difference [SMD]=-1.98, 95% confidence interval [CI]=-3.28 to -0.67, p=0.003) and improve the total effective rate (TER) (risk ratio [RR]=1.17, 95% CI=1.07 to 1.27, p=0.0004) in comparison to antidepressants. Furthermore, WGH combined with antidepressants led to a greater reduction in HAMD scores (SMD=-1.37, 95% CI=-1.73 to -1.01, p<0.00001) and improves TER (RR=1.18, 95% CI=1.08 to 1.29, p=0.0002) compared to antidepressants. Moreover, WGH had a lower risk of adverse events compared to antidepressants. No severe adverse events were reported. The overall risk of bias was high. The quality of evidence was low to moderate. Conclusions: The findings of the study suggest that WGH may offer therapeutic benefits for individuals experiencing PSD. Nevertheless, given the clinical heterogeneity and low methodological quality of the studies included, these results should be interpreted with caution. Therefore, further research on this subject is necessary.
Objectives: Post-stroke depression (PSD) is associated with increased mortality, exacerbated cognitive impairments, and diminished quality of life. Yueju-pill (Wolgukhwan, WGH) is a traditional herbal medicine from East Asia traditionally utilized for the treatment of depression. The objective of this review was to provide credible evidence regarding the efficacy and safety of WGH in the context of post-stroke depression. Methods: Thirteen electronic databases were systematically searched until September 14, 2024, and randomized controlled trials (RCTs) evaluating WGH for PSD were reviewed. The Cochrane Risk of Bias Tool version 5.1.0 and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool were employed for quality assessment. A meta-analysis was performed to assess the efficacy and safety of WGH for PSD. Results: A total of 16 RCTs involving 1,247 participants were included in the analysis. WGH was found to significantly reduce Hamilton Depression Scale (HAMD) scores (standardized mean difference [SMD]=-1.98, 95% confidence interval [CI]=-3.28 to -0.67, p=0.003) and improve the total effective rate (TER) (risk ratio [RR]=1.17, 95% CI=1.07 to 1.27, p=0.0004) in comparison to antidepressants. Furthermore, WGH combined with antidepressants led to a greater reduction in HAMD scores (SMD=-1.37, 95% CI=-1.73 to -1.01, p<0.00001) and improves TER (RR=1.18, 95% CI=1.08 to 1.29, p=0.0002) compared to antidepressants. Moreover, WGH had a lower risk of adverse events compared to antidepressants. No severe adverse events were reported. The overall risk of bias was high. The quality of evidence was low to moderate. Conclusions: The findings of the study suggest that WGH may offer therapeutic benefits for individuals experiencing PSD. Nevertheless, given the clinical heterogeneity and low methodological quality of the studies included, these results should be interpreted with caution. Therefore, further research on this subject is necessary.
Objectives: This study aims to investigate and analyze case studies on the treatment of dissociative symptoms, with a particular focus on acupuncture therapy. Methods: Relevant literature was identified from studies published up to October 30, 2024, using domestic databases such as DBPIA, KISS, and OASIS, as well as international databases, including PubMed, ScienceDirect, and CNKI. Studies involving acupuncture treatment for patients exhibiting dissociative symptoms were selected for analysis. Results: Of the 122 studies reviewed, six papers encompassing nine clinical cases were analyzed. Among these cases, seven involved dissociative amnesia, one involved dissociative identity disorder, and one involved the dissociative subtype of post-traumatic stress disorder (PTSD). A total of 59 acupuncture points were utilized. The most frequently used acupoint was GV20 (applied in five cases), followed by HT7, LI4, and LR3 (each used in four cases). Additionally, GV26, LU8, LU9, and SP6 were employed in three cases each. As part of combined treatment, several herbal medicine prescriptions, moxibustion, and cupping were utilized. Two evaluation tools were employed across the cases: a visual analogue scale (VAS) in one instance and a brief psychiatric rating scale (BPRS) in another. Conclusions: Although the number of cases analyzed is limited, this study is significant as it specifically examines the application of acupuncture in clinical practice for patients with dissociative symptoms. The findings of this study may contribute to informing future research on the efficacy of Korean medicine treatments for dissociative symptoms.
Objectives: This study aims to investigate and analyze case studies on the treatment of dissociative symptoms, with a particular focus on acupuncture therapy. Methods: Relevant literature was identified from studies published up to October 30, 2024, using domestic databases such as DBPIA, KISS, and OASIS, as well as international databases, including PubMed, ScienceDirect, and CNKI. Studies involving acupuncture treatment for patients exhibiting dissociative symptoms were selected for analysis. Results: Of the 122 studies reviewed, six papers encompassing nine clinical cases were analyzed. Among these cases, seven involved dissociative amnesia, one involved dissociative identity disorder, and one involved the dissociative subtype of post-traumatic stress disorder (PTSD). A total of 59 acupuncture points were utilized. The most frequently used acupoint was GV20 (applied in five cases), followed by HT7, LI4, and LR3 (each used in four cases). Additionally, GV26, LU8, LU9, and SP6 were employed in three cases each. As part of combined treatment, several herbal medicine prescriptions, moxibustion, and cupping were utilized. Two evaluation tools were employed across the cases: a visual analogue scale (VAS) in one instance and a brief psychiatric rating scale (BPRS) in another. Conclusions: Although the number of cases analyzed is limited, this study is significant as it specifically examines the application of acupuncture in clinical practice for patients with dissociative symptoms. The findings of this study may contribute to informing future research on the efficacy of Korean medicine treatments for dissociative symptoms.
Objectives: This study presents a scoping review of fMRI research on acupuncture for Alzheimer’s disease. It examines commonly used techniques, outcome measures, and identifies research gaps. The review aims to evaluate acupuncture treatment for cognitive impairment through fMRI, highlight methodological issues, and provide recommendations for future research. Methods: Controlled clinical trials utilizing fMRI in acupuncture treatment for human subjects were selected. A five-stage scoping review framework, based on Arksey and O’Malley’s methodology, was employed. Studies were assessed for their general characteristics, acupuncture methods, and compliance with STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines. Results were systematically organized into tables for clarity and reproducibility. Results: Ninety studies were identified, with 12 meeting the inclusion criteria. Participants included patients with Alzheimer’s, those with mild cognitive impairment, and healthy controls. Cognitive impairment was assessed using tools such as the MMSE and CDR. Common acupuncture points included LR3 and LI4. Electroacupuncture was utilized in five studies, while manual acupuncture was used in seven. The STRICTA evaluation indicated consistent reporting on acupuncture type and rationale, but limited detail regarding practitioner qualifications. Conclusions: This review reveals significant limitations in fMRI-based acupuncture studies for Alzheimer’s, including insufficient treatment sessions, a lack of disease-specific acupuncture points, few randomized controlled trials, unclear participant selection criteria, and inadequate adherence to STRICTA guidelines. Addressing these gaps with robust study designs is crucial for advancing the field and enabling high-quality reviews.
Objectives: This study presents a scoping review of fMRI research on acupuncture for Alzheimer’s disease. It examines commonly used techniques, outcome measures, and identifies research gaps. The review aims to evaluate acupuncture treatment for cognitive impairment through fMRI, highlight methodological issues, and provide recommendations for future research. Methods: Controlled clinical trials utilizing fMRI in acupuncture treatment for human subjects were selected. A five-stage scoping review framework, based on Arksey and O’Malley’s methodology, was employed. Studies were assessed for their general characteristics, acupuncture methods, and compliance with STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines. Results were systematically organized into tables for clarity and reproducibility. Results: Ninety studies were identified, with 12 meeting the inclusion criteria. Participants included patients with Alzheimer’s, those with mild cognitive impairment, and healthy controls. Cognitive impairment was assessed using tools such as the MMSE and CDR. Common acupuncture points included LR3 and LI4. Electroacupuncture was utilized in five studies, while manual acupuncture was used in seven. The STRICTA evaluation indicated consistent reporting on acupuncture type and rationale, but limited detail regarding practitioner qualifications. Conclusions: This review reveals significant limitations in fMRI-based acupuncture studies for Alzheimer’s, including insufficient treatment sessions, a lack of disease-specific acupuncture points, few randomized controlled trials, unclear participant selection criteria, and inadequate adherence to STRICTA guidelines. Addressing these gaps with robust study designs is crucial for advancing the field and enabling high-quality reviews.
Objectives: This case study aims to report on the effects of neurofeedback training, guided by Quantitative Electroencephalography (QEEG), on a pediatric patient diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD). Methods: The patient participated in a total of 30 sessions of neurofeedback training. Assessments related to ADHD, including QEEG, the Comprehensive Attention Test (CAT), the Abbreviated Conners Rating Scale (ACRS), the Korea-ADHD Rating Scale (K-ARS), and the Korea Language-Based Reading Assessment (KOLRA), were conducted both before and after the intervention to evaluate improvements. Results: The findings indicated significant improvements in the patient’s overall performance, encompassing cognitive abilities and interpersonal relationships. Conclusions: Neurofeedback training, guided by a preliminary QEEG assessment for individualized treatment, resulted in notable improvements in ADHD symptoms.
Objectives: This case study aims to report on the effects of neurofeedback training, guided by Quantitative Electroencephalography (QEEG), on a pediatric patient diagnosed with Attention Deficit/ Hyperactivity Disorder (ADHD). Methods: The patient participated in a total of 30 sessions of neurofeedback training. Assessments related to ADHD, including QEEG, the Comprehensive Attention Test (CAT), the Abbreviated Conners Rating Scale (ACRS), the Korea-ADHD Rating Scale (K-ARS), and the Korea Language-Based Reading Assessment (KOLRA), were conducted both before and after the intervention to evaluate improvements. Results: The findings indicated significant improvements in the patient’s overall performance, encompassing cognitive abilities and interpersonal relationships. Conclusions: Neurofeedback training, guided by a preliminary QEEG assessment for individualized treatment, resulted in notable improvements in ADHD symptoms.
Objectives: This study aimed to evaluate the effects of neurofeedback training in a patient with chronic insomnia who had a long-term history of sleep medication use. Methods: A 56-year-old woman with an Insomnia Severity Index score of 16 participated in 10 neurofeedback sessions over four weeks. The training focused on enhancing sensorimotor rhythm while inhibiting theta and high beta waves. Comprehensive assessments were conducted to measure changes in subjective and objective indicators of insomnia before and after the intervention. These assessments included sleep quality evaluation, insomnia severity, quantitative EEG, polysomnography, actigraphy, and sleep diaries. Results: Following neurofeedback training, no consistent changes were observed in objective indices. However, subjective measures, such as sleep quality and emotional state, showed improvement during the follow-up. No adverse events were reported. Conclusions: Neurofeedback training appears to be a safe and effective non-pharmacological treatment for insomnia, leading to improvements in sleep quality and related subjective symptoms. Further research with personalized protocols, larger sample sizes, and longer treatment durations is necessary to confirm its efficacy and safety.
Objectives: This study aimed to evaluate the effects of neurofeedback training in a patient with chronic insomnia who had a long-term history of sleep medication use. Methods: A 56-year-old woman with an Insomnia Severity Index score of 16 participated in 10 neurofeedback sessions over four weeks. The training focused on enhancing sensorimotor rhythm while inhibiting theta and high beta waves. Comprehensive assessments were conducted to measure changes in subjective and objective indicators of insomnia before and after the intervention. These assessments included sleep quality evaluation, insomnia severity, quantitative EEG, polysomnography, actigraphy, and sleep diaries. Results: Following neurofeedback training, no consistent changes were observed in objective indices. However, subjective measures, such as sleep quality and emotional state, showed improvement during the follow-up. No adverse events were reported. Conclusions: Neurofeedback training appears to be a safe and effective non-pharmacological treatment for insomnia, leading to improvements in sleep quality and related subjective symptoms. Further research with personalized protocols, larger sample sizes, and longer treatment durations is necessary to confirm its efficacy and safety.
Objectives: Adjustment disorder (AJD) is a maladaptive reaction to an identifiable psychosocial stressor or multiple stressors. The objective of this clinical case study was to report the efficacy of Oriental psychotherapy including Rogers’ person-centered counseling in treating AJD. Methods: For a female subject in her 50s who was diagnosed with AJD, Korean Medicine Psychotherapy including Roger’s person-centered counseling was used for treatment. Her treatment also included herbal medicine, acupuncture, moxibustion, and cupping therapy that lasted for 105 days. Changes in Numeric Rating Scale (NRS), Beck Depression Index (BDI), Pittsburgh Sleep Quality Index (PSQI), and patient’s subjectively reported symptoms were assessed. Results: Although psychiatric medication dosage was reduced the during the treatment process, improvements were observed in the patient’s subjectively reported symptoms and NRS scores after treatment. In the initial phase, symptoms fluctuated in response to stress levels. However, the patient gradually demonstrated improved coping strategies, although her changes of BDI and PSQI were not statistically significant. Conclusions: These outcomes suggest that traditional Korean psychotherapy including Roger’s person-centered counseling is effective in treating AJD.
Objectives: Adjustment disorder (AJD) is a maladaptive reaction to an identifiable psychosocial stressor or multiple stressors. The objective of this clinical case study was to report the efficacy of Oriental psychotherapy including Rogers’ person-centered counseling in treating AJD. Methods: For a female subject in her 50s who was diagnosed with AJD, Korean Medicine Psychotherapy including Roger’s person-centered counseling was used for treatment. Her treatment also included herbal medicine, acupuncture, moxibustion, and cupping therapy that lasted for 105 days. Changes in Numeric Rating Scale (NRS), Beck Depression Index (BDI), Pittsburgh Sleep Quality Index (PSQI), and patient’s subjectively reported symptoms were assessed. Results: Although psychiatric medication dosage was reduced the during the treatment process, improvements were observed in the patient’s subjectively reported symptoms and NRS scores after treatment. In the initial phase, symptoms fluctuated in response to stress levels. However, the patient gradually demonstrated improved coping strategies, although her changes of BDI and PSQI were not statistically significant. Conclusions: These outcomes suggest that traditional Korean psychotherapy including Roger’s person- centered counseling is effective in treating AJD.